Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Aug 2, 2022, before the open
10-Q filed Aug 3, 2022, 34 days after period end · 0001558370-22-011888
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $9.07M | $274.00K | — | — |
| Net Income | -$45.00M | -$35.39M | -$31.12M | -$42.80M |
| EPS Diluted |
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
| -$0.89 |
| -$0.70 |
| -$0.71 |
| -$1.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.